• Virtual Workshop 12-16 October 2020
    Virtual Workshop 12-16 October 2020
  • Virtual Global Workshop 11-13 May 2020
    Virtual Global Workshop 11-13 May 2020
  • Tokyo 2-3 December 2019
    Tokyo 2-3 December 2019
  • Zurich 28-30 October 2019
    Zurich 28-30 October 2019
  • Peapack 14-16 October 2019
    Peapack 14-16 October 2019
  • Brussels 15-17 May 2019
    Brussels 15-17 May 2019
  • Danbury 8-10 April 2019
    Danbury 8-10 April 2019

WHO WE ARE

The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.


News from the eCF

Login to also view news for Members.

Technology Showcase: Challenges to the Adoption of Paperless Trials During the COVID-19 Epidemic and Beyond

December 1 at UTC 1500 and recording

Event date: 12/1/2020 Export event

Technology Showcase: Challenges to the Adoption of Paperless Trials During the COVID-19 Epidemic and Beyond

Technology Showcase: Target Health – Challenges to the Adoption of Paperless Trials During the COVID-19 Epidemic and Beyond

Open To: Staff from eClinical Forum member companies. For information on eCF membership, please see www.eclinicalforum.org/membership or send an inquiry to info@eclinicalforum.org.

Background: This is an eClinical Forum Technology Showcase. Our Technology Showcase sessions have been requested by eCF members to provide a demonstration of products or services, and by necessity are not technology or vendor neutral. The eClinical Forum does not promote nor endorse any particular technology vendors. Any member can participate that has an interest in the topic area.  Any eClinical Forum Member may suggest or present a Technology Showcase. For more information, please reply to info@eclinicalforum.org.

Presenter:  Dr. Jules Mitchel, Target Health

About this Topic:  Clearly, the implementation of traditional clinical research studies as well as executing COVID-19 studies themselves. have been dramatically impacted by global COVID-19 pandemic.  Since showing up at clinical sites in general is becoming less feasible, clinical research must adapt. While there are many exciting ideas to execute virtual and remote studies, the focus still needs to be on the assurances that 1. the clinical sites understand and are following the protocol; 2. the data can and are being entered and reviewed in “real time,” 3. there are the “absence of errors that matter” and 4. the “data are fit for purpose.”  This session will showcase several studies using a web-based application, with Informed Consent fully integrated with real time direct data capture, real time reports, online monitoring reports and safety reporting.

Date: Tues, December 1 2020        Duration: One hour

Time: Webinar at UTC 1500.  This webinar will also be recorded so that all eCF Asia-Pacific members and other members who have time conflicts can review at a more convenient time.  Please also register if you are interested in the recording.

eClinical Forum Membership registration: https://eclinicalforum.org/Forms/TS-Paperless-Trials

Non-members: Please review membership information on this website in the membership tab, or contact us for more information: info@eclinicalforum.org

 

Print
Tags:
Rate this article:
No rating

NOT A MEMBER?

Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)
«January 2021»
MonTueWedThuFriSatSun
28293031123
45678910
11121314151617
18192021222324
2526
Birds-of-a-Feather Round Table Discussion:  New recommendations from EMA on the frequency of investigators’ signature collection on eCRF data

Birds-of-a-Feather Round Table Discussion: New recommendations from EMA on the frequency of investigators’ signature collection on eCRF data

In July 2020, EMA released a new Q&A to provide further expectations on continuous oversight and frequency of investigators’ signature collection on eCRF data reported to the sponsor. Prior to filing a marketing authorization application, all eCRF data should be signed and dated. But also important data such as that related to reporting of SAEs, adjudication of important events and endpoint data, DSMB review, should be signed off in a timely manner. In addition, a timely review and sign-off of data that are entered directly into the CRF as source is particularly important.

The intent of this webinar is to identify if there are new challenges, and if any – to proceed with an update to the eCF best practices on investigator signatures document that was released in 2017.

Read more
2728293031
1234567

Upcoming events Events RSSiCalendar export